Enzo Biochem (ENZ:NYSE) Investor Relations Material

Overview

Enzo Biochem, Inc. is an all-encompassing company that focuses on diagnostics, clinical lab and life sciences. The New York-based company specializes in developing, researching and manufacturing diagnostic and research products that are based on genetic engineering, biotechnology and molecular biology. Enzo operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products segment provides its customers with tools for target identification/validation, gene expression analysis, nucleic acid detection and more. The Clinical Laboratory Services segment offers molecular and other clinical laboratory tests to establish or support a diagnosis, monitor treatment or medication and search for an otherwise undiagnosed condition. The entire process can be completed through the numerous service centers and laboratories that Enzo operates in New York and New Jersey. The final segment, Therapeutics, specializes in developing innovative approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases. Enzo's unique blend of services and product offerings have made them a leader in the industry since its inception in 1976.

Frequently Asked Questions

What is Enzo Biochem's ticker?

Enzo Biochem's ticker is ENZ

What exchange is Enzo Biochem traded on?

The company's shares trade on the NYSE stock exchange

Where are Enzo Biochem's headquarters?

They are based in New York City, New York

How many employees does Enzo Biochem have?

There are 201-500 employees working at Enzo Biochem

What is Enzo Biochem's website?

It is enzo.com

What type of sector is Enzo Biochem?

Enzo Biochem is in the Healthcare sector

What type of industry is Enzo Biochem?

Enzo Biochem is in the Medical Laboratories & Research industry

Who are Enzo Biochem's peers and competitors?

The following five companies are Enzo Biochem's industry peers:

- ObsEva

- Ingenia Communities Group

- Quest Diagnostics

- Organovo Holdings Inc

- Biocept